About Clinical Trials

Clinical trials are a partnership between people affected by diabetes and doctors to help find ways to treat, predict, prevent, and reverse the disease. These trials also seek to improve day-to-day diabetes management and prevent diabetes-related complications. Each study tries to answer specific scientific questions. Clinical trials that involve patients are the final stage of careful and extensive diabetes research taking place in the laboratory. Participants in clinical trials are offered the opportunity to play a more active role in their own health care, learn about new research treatments, and help others by contributing to medical research.

Every clinical trial at the Diabetes Center of Excellence is approved and monitored by the UF Institutional Review Board (IRB) to make sure the risks are as low as possible and are worth any potential benefits. An IRB is an independent committee of physicians, statisticians, community advocates, and others that ensures that the rights of the participants are protected and that the study is ethical.

The clinical trials currently underway at the University of Florida receive funding from the National Institutes of Health, the Juvenile Diabetes Research Foundation, the American Diabetes Association, and the International Diabetes Federation.

For more information about past and present clinical trials at the University of Florida Diabetes Center of Excellence, please explore our current clinical trials listed on this site or contact Annie Abraham at (352) 334-1358.

Translational Research: From the Laboratory to the Patient

The University of Florida (UF) Diabetes Center of Excellence is an international leader in type 1 diabetes research. Our team is dedicated to understanding the causes of type 1 diabetes and investigating therapies to treat and ultimately cure the disease.

Key to this mission is collaborative research between scientists who work in the laboratory and physicians who work directly with patients. This “bench-to-bedside” model means that scientific findings in the laboratory can be translated into medical treatments with the potential to benefit those who live with diabetes. We hope to learn how to prevent type 1 diabetes by gaining a clear understanding of the interplay between genetic predisposition and environmental triggers. We also seek to test safe, innovative new therapies that might mitigate beta cell destruction and reduce the person’s dependence on insulin.

 

For more information about clinical trials at the University of Florida Diabetes Center of Excellence, please contact:

Annie Abraham
Recruitment Coordinator
Diabetes Research Group
University of Florida
Box 100296 Gainesville, FL 32610

Phone: 352-334-0857
Direct line: 352-334-1358
Fax: 352-334-1777

email: abraa@peds.ufl.edu